The DOI matches its Crossref record; 488 of the 488 references it cites were found in a registry or an index.
Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
Open accessAbstract
Colon cancer is the third most common cancer worldwide. Most colorectal cancer occurrences are sporadic, not related to genetic predisposition or family history; however, 20–30% of patients with colorectal cancer have a family history of colorectal cancer and 5% of these tumors arise in the setting of a Mendelian inheritance syndrome. In many patients, the development of a colorectal cancer is preceded by a benign neoplastic lesion: either an adenomatous polyp or a serrated polyp. Studies carried out in the last years have characterized the main molecular alterations occurring in colorectal cancers, showing that the tumor of each patient displays from two to eight driver mutations. The ensemble of molecular studies, including gene expression studies, has led to two proposed classifications of colorectal cancers, with the identification of four/five non-overlapping groups. The homeostasis of the rapidly renewing intestinal epithelium is ensured by few stem cells present at the level of the base of intestinal crypts. Various experimental evidence suggests that colorectal cancers may derive from the malignant transformation of intestinal stem cells or of intestinal cells that acquire stem cell properties following malignant transformation. Colon cancer stem cells seem to be involved in tumor chemoresistance, radioresistance and relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–488 of 488
DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis
Befrits, R., Hammarberg, C., Rubio‐Terres, C., Jaramillo, E., & Tribukait, B. (1994) · Diseases of the Colon & Rectum · doi:10.1007/bf02053590 · Cited by 63
Srinivasan, T., Walters, J. N., Bu, P., Than, E. B., Tung, K., Chen, K., Panarelli, N. C., Milsom, J., Augenlicht, L. H., Lipkin, S. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3198 · Cited by 63
Association between clinicopathological characteristics and RAS mutation in colorectal cancer
Rimbert, J., Tachon, G., Junca, A., Villalva, C., Karayan, L., & Tougeron, D. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.119 · Cited by 63
Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers
Lan, Y., Lin, J., Lin, C., Yang, S., Lin, C., Wang, H., Chen, W., Lin, T., Jiang, J., & Chang, S. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23895 · Cited by 62
RSPO fusion transcripts in colorectal cancer in Japanese population
Shinmura, K., Kahyo, T., Kato, H., Igarashi, H., Matsuura, S., Nakamura, S., Kurachi, K., Nakamura, T., Ogawa, H., Funai, K., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3409-x · Cited by 62
Alvi, M. A., Loughrey, M. B., Dunne, P. D., McQuaid, S., Turkington, R. C., Fuchs, M.-A., McGready, C., Bingham, V., Pang, B., Moore, W., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.168 · Cited by 62
Xue, Y., Johnson, R., DeSmet, M. L., Snyder, P. W., & Fleet, J. C. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0195 · Cited by 61
Hua, X., Phipps, A. I., Burnett‐Hartman, A. N., Adams, S. V., Hardikar, S. S., Cohen, S. A., Kocarnik, J., Ahnen, D. J., Lindor, N. M., Baron, J. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3569 · Cited by 61
Logarithmic expansion of LGR5 + cells in human colorectal cancer
Martín, M. L., Zeng, Z., Adileh, M., Jacobo, A., Li, C., Vakiani, E., Hua, G., Zhang, L., Haimovitz‐Friedman, A., FUKS, Z. Y., et al. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.018 · Cited by 61
Joosten, S. P. J., Zeilstra, J., van Andel, H., Mijnals, R. C. D., Zaunbrecher, J., Duivenvoorden, A. A. M., van de Wetering, M., Clevers, H. C., Spaargaren, M., & Pals, S. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.008 · Cited by 59
Haley, L. M., Tseng, L., Zheng, G., Dudley, J. C., Anderson, D. A., Azad, N. S., Gocke, C. D., Eshleman, J. R., & Lin, M. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.86 · Cited by 58
Kothari, N., Teer, J. K., Abbott, A. M., Srikumar, T., Zhang, Y., Yoder, S., Brohl, A. S., Kim, R. D., Reed, D. R., & Shibata, D. (2016) · Cancer · doi:10.1002/cncr.30082 · Cited by 58
E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling
Dominguez‐Brauer, C., Khatun, R., Elia, A., Thu, K. L., Ramachandran, P., Baniasadi, S. P., Hao, Z., Jones, L. D., Haight, J., Sheng, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621355114 · Cited by 58
Mice Expressing Activated PI3K Rapidly Develop Advanced Colon Cancer
Leystra, A. A., Deming, D. A., Zahm, C. D., Farhoud, M., Olson, T. J. P., Hadac, J. N., Nettekoven, L. A., Albrecht, D. M., Clipson, L. J., Sullivan, R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4097 · Cited by 57
Suzuki, Y., Ng, S. B. H., Chua, C., Leow, W. Q., Chng, J., Liu, S., Ramnarayanan, K., Gan, A., Ho, D. L., Ten, R., et al. (2016) · Molecular Oncology · doi:10.1002/1878-0261.12012 · Cited by 56
High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
Jeantet, M., Tougeron, D., Tachon, G., Cortes, U., Archambaut, C., Fromont, G., & Karayan, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122015 · Cited by 55
DPC4 gene mutation in colitis associated neoplasia.
Hoque, A. T. M. S., Hahn, S. A., Schutte, M. E. M., & Kern, S. E. (1997) · Gut · doi:10.1136/gut.40.1.120 · Cited by 53
The molecular landscape of colitis-associated carcinogenesis
Saraggi, D., Fassan, M., Mescoli, C., Scarpa, M., Valeri, N., Michielan, A., Renata D'Incà, & Rugge, M. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.12.011 · Cited by 53
Riemer, P., Sreekumar, A., Reinke, S., Rad, R., Schäfer, R., Sers, C., Bläker, H., Herrmann, B. G., & Morkel, M. (2014) · Oncogene · doi:10.1038/onc.2014.247 · Cited by 52
Martínez‐Cardús, A., Morán, S., Musulén, E., Moutinho, C., Manzano, J. L., Martinez‐Balibrea, E., Tierno, M., Élez, E., Landolfi, S., Lorden, P., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.001 · Cited by 52
Alwers, E., Jia, M., Kloor, M., Bläker, H., Brenner, H., & Hoffmeister, M. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.12.038 · Cited by 52
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome
Binder, H., Hopp, L., Schweiger, M. R., Hoffmann, S., Jühling, F., Kerick, M., Timmermann, B., Siebert, S., Grimm, C., Nersisyan, L., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4948 · Cited by 51
Sievers, C. K., Zou, L. S., Pickhardt, P. J., Matkowskyj, K. A., Albrecht, D. M., Clipson, L. J., Bacher, J. W., Pooler, B. D., Moawad, F. J., Cash, B. D., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312232 · Cited by 47
Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis
Dempsey, P. J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.07.011 · Cited by 47
Tian, X., Zhu, X., Yan, T., Yu, C., Shen, C., Hu, Y., Hong, J., Chen, H., & Fang, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12117 · Cited by 47
Oost, K. C., van Voorthuijsen, L., Fumagalli, A., Lindeboom, R. G. H., Sprangers, J., Omerzu, M., Colman, M. J. R., Heinz, M. C., Verlaan-Klink, I., Maurice, M. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.033 · Cited by 47
Molecular pathways: sensitivity and resistance to anti-EGFR antibodies
Bertotti, A., & Sassi, F. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0848 · Cited by 45
Prieur, A., Cappellini, M., Habif, G., Lefranc, M., Mazard, T., Morency, E., Pascussi, J., Flacelière, M., Cahuzac, N., Vire, B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0533 · Cited by 44
Árnadóttir, S. S., Jeppesen, M., Lamy, P., Bramsen, J. B., Nordentoft, I., Knudsen, M., Vang, S., Madsen, M. R., Thastrup, M., Thastrup, J., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12156 · Cited by 44
Prognostic impact of mutation profiling in patients with stage II and III colon cancer
Shen, Y., Han, X., Wang, J., Wang, S., Yang, H., Lu, S.-H., & Shi, Y. (2016) · Scientific Reports · doi:10.1038/srep24310 · Cited by 43
Cohen, S. A., Turner, E. H., Beightol, M., Jacobson, A. L., Gooley, T. A., Salipante, S. J., Haraldsdóttir, S., Smith, C., Scroggins, S. M., Tait, J. F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.004 · Cited by 43
Neuroendocrine differentiation: The mysterious fellow of colorectal cancer
Kleist, B. A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11740 · Cited by 43
Irshad, S., Bansal, M., Guarnieri, P., Belnoue-Davis, H. L., Zen, A. A. H., Baran, B., Pinna, C. M. A., Rahman, H., Biswas, S., Bardella, C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4891 · Cited by 43
Concordant DNA Methylation in Synchronous Colorectal Carcinomas
Konishi, K., Shen, L., Jelínek, J., Watanabe, Y., Ahmed, S., Kaneko, K., Kogo, M., Takano, T., Imawari, M., Hamilton, S. R., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0054 · Cited by 42
Tsai, J., Liau, J., Yuan, C., Lin, Y., Tseng, L., Cheng, M.-L., & Jeng, Y. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000664 · Cited by 41
Jesinghaus, M., Wolf, T. A., Pfarr, N., Muckenhuber, A., Ahadova, A., Warth, A., Goeppert, B. F., Sers, C., Kloor, M., Endris, V., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000423 · Cited by 40
Catch my drift? Making sense of genomic intra-tumour heterogeneity
Sottoriva, A., Barnes, C. P., & Graham, T. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.003 · Cited by 40
Ubink, I., Elias, S. G., Moelans, C. B., Laclé, M. M., van Grevenstein, W. M. U., van Diest, P. J., Borel Rinkes, I. H. M., & Kranenburg, O. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw303 · Cited by 40
New insights into the earliest stages of colorectal tumorigenesis
Sievers, C. K., Grady, W. M., Halberg, R. B., & Pickhardt, P. J. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1330150 · Cited by 40
Distribution of intestinal stem cell markers in colorectal precancerous lesions
Jang, B. G., Kim, H. S., Kim, K. J., Rhee, Y.-Y., Kim, W. H., & Kang, G. H. (2015) · Histopathology · doi:10.1111/his.12787 · Cited by 39
Sarkar, S., Popov, V. L., O’Connell, M. R., Stevenson, H. L., Lee, B. S., Obeid, R. A., Luthra, G. K., & Singh, P. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.40 · Cited by 39
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
Giessler, K. M., Kleinheinz, K., Hüebschmann, D., Balasubramanian, G. P., Dubash, T. D., Dieter, S. M., Siegl, C., Herbst, F., Weber, S., Hoffmann, C. M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20162017 · Cited by 39
Hurwitz, H. I., Raghav, K. P. S., Burris, H. A., Kurzrock, R., Sweeney, C. J., Meric‐Bernstam, F., Vanderwalde, A. M., Spigel, D. R., Bose, R., Fakih, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.676 · Cited by 38
FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer
Sarkar, S., O’Connell, M. R., Okugawa, Y., Lee, B. S., Toiyama, Y., Kusunoki, M., Daboval, R. D., Goel, A., & Singh, P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0287 · Cited by 38
Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors
Park, C., Ha, S. Y., Kim, S. T., Kim, H. C., Heo, J. S., Park, Y. S., Lauwers, G. Y., Lee, J., & Kim, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6602 · Cited by 37
Yuan, W., Zhang, Z., Dai, B., Wei, Q., Liu, J., Liu, Y., Liu, Y., He, L., & Zhou, D. (2016) · Cancer · doi:10.1002/cncr.29974 · Cited by 37
Gausachs, M., Borràs, E., Chang, K., González, S., Azuara, D., Amador, A. D., López‐Doriga, A., Lucas, F. A. S., Sanjuán, X., Paúles, M. J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0821 · Cited by 37
Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells
Gu, M., Nishihara, R., Chen, Y., Li, W., Shi, Y. X., Masugi, Y., Hamada, T., Kosumi, K., Liu, L., da Silva, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20972 · Cited by 36
Miller, T. J., McCoy, M. J., Hemmings, C., Bulsara, M. K., Iacopetta, B. M., & Platell, C. F. E. (2017) · Pathology · doi:10.1016/j.pathol.2017.08.007 · Cited by 36
Sharma, A., Gadkari, R. A., Ramakanth, S. V., Padmanabhan, K., Madhumathi, D. S., Devi, L., Appaji, L., Aster, J. C., Rangarajan, A., & Dighe, R. R. (2015) · Scientific Reports · doi:10.1038/srep11012 · Cited by 34
Yamaguchi, T., Iijima, T., Mori, T., Takahashi, K., Matsumoto, H., Miyamoto, H., Hishima, T., & Miyaki, M. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0293-4 · Cited by 33
Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors
Thliveris, A. T., Schwefel, B., Clipson, L. J., Plesh, L. K., Zahm, C. D., Leystra, A. A., Washington, M. K., Sullivan, R., Deming, D. A., Newton, M. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303064110 · Cited by 33
Distinct Roles of HES1 in Normal Stem Cells and Tumor Stem-like Cells of the Intestine
Goto, N., Ueo, T., Fukuda, A., Kawada, K., Sakai, Y., Miyoshi, H., Taketo, M. M., Chiba, T., & Seno, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3192 · Cited by 33
Lonardi, S., André, T., Wong, K. Y. M., Morse, M. A., McDermott, R., Hill, A., Hendlisz, A., Lenz, H., Leach, J. W., Moss, R. A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx422.001 · Cited by 33
Repairing organs: lessons from intestine and liver
Gehart, H., & Clevers, H. C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.04.005 · Cited by 32
Many private mutations originate from the first few divisions of a human colorectal adenoma
Kang, H., Salomon, M. P., Sottoriva, A., Zhao, J., Toy, M., Press, M. F., Curtis, C. N., Marjoram, P., Siegmund, K. D., & Shibata, D. K. (2015) · The Journal of Pathology · doi:10.1002/path.4581 · Cited by 32
Whole-exome sequencing identified mutational profiles of high-grade colon adenomas
Lee, S. H., Jung, S. H., Kim, T.-M., Rhee, J., Park, H., Kim, S. S., Kim, S. S., An, C. H., Lee, S. H., & Chung, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.14172 · Cited by 32
Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
König, A. O., Krug, S., Mueller, D., Barth, P. J., Koenig, U., Scharf, M. E., Ellenrieder, V., Michl, P., Moll, R., Homayunfar, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188876 · Cited by 32
Tian, A., Benchabane, H., Wang, Z., Zimmerman, C., Xin, N., Perochon, J., Kalna, G., Sansom, O. J., Cheng, C., Cordero, J. B., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006870 · Cited by 31
Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
Chang, C.-C., Lin, P.-C., Lin, C., Lan, Y., Lin, H., Lin, C., Yang, S.-H., Liang, W.-Y., Chen, W.-S., Jiang, J., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071441 · Cited by 30
Dominguez‐Brauer, C., Hao, Z., Elia, A., Fortin, J., Nechanitzky, R., Brauer, P. M., Sheng, Y., Mana, M., Chio, I. I. C., Haight, J., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.04.002 · Cited by 28
Kim, K., Kim, J., Hong, Y. S., Ahn, S., Chun, S., Hong, S., Jang, S. J., Yu, C. S., Kim, J. C., & Kim, T. W. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2015.490 · Cited by 27
Percolation transition of cooperative mutational effects in colorectal tumorigenesis
Shin, D., Lee, J., Gong, J., & Cho, K. (2017) · Nature Communications · doi:10.1038/s41467-017-01171-6 · Cited by 27
André, T., Lonardi, S., Wong, K. Y. M., Morse, M. A., McDermott, R., Hill, A. G., Hendlisz, A., Lenz, H., Leach, J. W., Moss, R. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3531 · Cited by 27
Jesinghaus, M., Pfarr, N., Kloor, M., Endris, V., Tavernar, L., Muckenhuber, A., Doeberitz, M. V. K., Penzel, R., Weichert, W., & Stenzinger, A. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22330 · Cited by 26
Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer
Zlobec, I., Bihl, M., Foerster, A., Rufle, A., Terracciano, L., & Lugli, A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00007 · Cited by 25
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
Chen, K.-H., Lin, Y., Liau, J., Tsai, J., Tseng, L., Lin, L., Liang, J., Lin, B., Hung, J., Chang, Y., et al. (2016) · Medical Oncology · doi:10.1007/s12032-016-0756-6 · Cited by 25
Sporadic early-onset colon cancer expresses unique molecular features
Jandová, J., Xu, W., & Nfonsam, V. N. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.04.068 · Cited by 25
de Macêdo, M. P., de Melo, F. M., Ribeiro, J. S., de Mello, C. A. L., Begnami, M. D. F. D. S., Soares, F. A., Carraro, D. M., & da Cunha, I. W. (2015) · Oncoscience · doi:10.18632/oncoscience.118 · Cited by 23
Sebagh, M., Allard, M., Bosselut, N., Dao, M., Vibert, É., Lewin, M., Lemoine, A., Cherqui, D., Adam, R. A., & Cunha, A. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7809 · Cited by 23
Dunne, P. D., O’Reilly, P. G., Coleman, H. G., Gray, R. T., Longley, D. B., Johnston, P. G., Salto‐Tellez, M., Lawler, M., & McArt, D. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9126 · Cited by 23
Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior
Hashimoto, K., Yamada, Y., Semi, K., Yagi, M., Tanaka, A., Itakura, F., Aoki, H., Kunisada, T., Woltjen, K., Haga, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614197114 · Cited by 22
Fischer, J. M., Calabrese, P. P., Miller, A., Muñoz, N. M., Grady, W. M., Shibata, D. K., & Liskay, R. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611980113 · Cited by 21
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia
Malesci, A., Basso, G., Bianchi, P. P., Fini, L., Grizzi, F., Celesti, G., Caro, G. D., Delconte, G., Dattola, F., Repici, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.827 · Cited by 20
KRAS and Cancer Stem Cells in APC-Mutant Colorectal Cancer
Fearon, E. R., & Wicha, M. S. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt444 · Cited by 19
BRAF mutation in colorectal carcinomas with signet ring cell component
Yalçın, S., & Öngürü, Ö. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0053 · Cited by 19
Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients
Hankey, W., McIlhatton, M. A., Ebede, K., Kennedy, B., Hancioglu, B., Zhang, J., Brock, G. N., Huang, K., & Groden, J. L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1357 · Cited by 19
Adua, D., Fabio, F. D., Ercolani, G., Fiorentino, M., Gruppioni, E., Altimari, A., Llimpe, F. L. R., Normanno, N., Pinna, A. D., & Pinto, C. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1270 · Cited by 18
The expression of CD44v6 in colon: from normal to malignant
Afify, A. M., Durbin-Johnson, B. P., Virdi, A., & Jess, H. (2015) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2015.10.010 · Cited by 17
Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis
Cheung, A. H. K., Iyer, D. N., Lam, C., Ng, L., Wong, S. H., Lee, H.-S., Wan, T. M.-H., Man, J. H.-W., Chow, A. K.-M., Poon, R. T. P., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061106 · Cited by 17
Peng, Q., Lin, K., Chang, T., Zou, L., Xing, P., Shen, Y., & Zhu, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s154207 · Cited by 16
Nakata, T., Shimizu, H., Nagata, S., Ito, G., Fujii, S., Suzuki, K., Kawamoto, A., Ishibashi, F., Kuno, R., Anzai, S., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.031 · Cited by 15
Kim, D., Kim, S. Y., Lee, J. S., Hong, Y. S., Kim, J. E., Kim, K., Kim, J., Jang, S. J., Yoon, Y., & Kim, T. W. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0694-6 · Cited by 15
Drew, D. A., Mo, A., Grady, J. J., Stevens, R. G., Levine, J. B., Brenner, B. M., Anderson, J. C., Forouhar, F., O’Brien, M. J., Devers, T. J., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0380 · Cited by 15
Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer
McCleary, N. J., Sato, K., Nishihara, R., Inamura, K., Morikawa, T., Zhang, X., Wu, K., Yamauchi, M., Kim, S. A., Sukawa, Y., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0946 · Cited by 13
Injury-associated reacquiring of intestinal stem cell function
Sípos, F., & Műzes, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i7.2005 · Cited by 10
Objective analysis of cancer stem cell marker expression using immunohistochemistry
Miller, T. J., McCoy, M. J., Hemmings, C., Bulsara, M. K., Iacopetta, B. M., & Platell, C. F. E. (2016) · Pathology · doi:10.1016/j.pathol.2016.09.063 · Cited by 9
Louvard, D., Sigaux, F., & Robine, S. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004102 · Cited by 1
Cited by
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Hossain, M. S., Kader, M. A., Goh, K. W., Islam, M., Khan, M. S., Harun-Ar Rashid, M., Ooi, D. J., Melo Coutinho, H. D., Al-Worafi, Y. M., Moshawih, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865801 · Cited by 346
SOX9 stem-cell factor: clinical and functional relevance in cancer
Aguilar-Medina, M., Avendaño-Félix, M., Lizárraga-Verdugo, E., Bermúdez, M., Romero-Quintana, J. G., Ramos-Payan, R., Ruíz-García, E., & López-Camarillo, C. (2019) · Journal of Oncology · doi:10.1155/2019/6754040 · Cited by 97
Metadata
- Authors
- Testa, U., Pelosi, E., & Castelli, G.
- Venue
- Medical Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-13
- Volume
- 6
- Issue
- 2
- Pages
- 31
- ISSN
- 2076-3271 (ISSN-L)
- OpenAlex
- W2797653557
- Cited by
- 374
- References
- 488
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.